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1. Introduction
The cellular prion protein (PrPC) is expressed as a cell surface protein mainly in 
the central and peripheral nervous system, as well as in some cells and organs of the 
immune system (leukocytes and the spleen), the reproductive system (the testes 
and ovaries), and others, such as Peyer’s patches in the intestinal tract, heart, lungs, 
and skeletal muscles, spreading to almost all parts of the body [1]. Prions were only 
relatively recently revealed to act as infectious agents although the diseases they 
cause have been known for a long time—initially attributed to toxic, genetic, and 
psychological factors and “unconventional viruses”—as our understanding of their 
mechanism evolved together with the methodological advancements.
The discovery that prions are infectious agents changed the concept of protein 
synthesis in modern biology and built a bridge between the genesis of infectious 
and genetic diseases.
The normal distribution of PrPC in certain organs correlates with the patho-
genesis route of some prion diseases, such as scrapie, Kuru, bovine spongiform 
encephalopathy (BSE), new variant Creutzfeldt-Jakob disease (vCJD), chronic 
wasting disease (CWD), and feline spongiform encephalopathy (FSE), probably 
acting as a “transformer and conductor” of the infectious isoform.
From a historical perspective, scrapie—as a disease of sheep—was a subject of 
discussion in the British parliament back in 1755; however, it was not until 1936 that 
Cullie and Chelle proved its contagious character by experimental infection [2]. 
Studies demonstrated genetic predisposition to development of the disease [3].
The disease bovine spongiform encephalopathy (BSE) was first identified and 
reproduced in 1986 in the United Kingdom [4]. It resulted from an incinerating 
technology introduced in the 1970s that worked at a lower disposal temperature 
and the supplementation of calf feed mixtures with meat-bone meal from scrapie 
sheep.
In Wisconsin, USA, in 1947, the disease transmissible mink encephalopathy 
(TME) was reported, arising from the use of sheep carcasses for food. Due to the 
cannibalism existing among minks and the passages through them, the etiological 
agent has undergone changes (e.g., it is nonpathogenic to mice) [2]. Another prion 
disease in animals is chronic wasting disease (CWD), which affects cervids includ-
ing deer, elk, and moose. It was described by Williams and Young in 1980 [5], and 
no genetic determinant was detected for its development.
Feline spongiform encephalopathy (FSE) was first reported as a disease in 
members of family Felidae in a zoo in the UK [6] and in other carnivorous animals. 
Eventually, the infection was demonstrated to originate from BSE [7], the source of 
infection being contaminated food. BSE is also the etiological agent of diseases in 
Nyala, Kudu—exotic ungulate encephalopathy (EUE)—and Lemurs (NHP—BSE in 
nonhuman primates) [6, 8].
There is a direct relationship between the prion diseases in animals and humans 
due to the ability of BSE to jump the barrier between species (via contaminated 
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food) and the emergence of a new variant of CJD in the UK in 1996 [9, 10] affecting 
mainly young people aged 27–35 years. The prions isolated from these patients are 
glycosylated at two sites (like BSE), and their gene encoding PrP has a characteristic 
homozygosity at codon 129 (methionine-methionine) [2].
Creutzfeldt–Jakob disease (CJD) was reported back in 1920 [11], and the 
elucidation of the etiology of Kuru (see below) prompted Gajdusek and coworkers 
to prove the infectious nature of this disease (CJD) by successfully transmitting it 
to chimpanzees and other species of monkeys. The disease may be manifested in 
several epidemic forms: iatrogenic CJD (iCJD) [12] resulting from surgical inter-
ventions (corneal grafting), use of contaminated electrodes in encephalography, 
sporadic CJD (sCJD) resulting from spontaneous mutations [11], and other TSE 
diseases associated with mutations in the coding gene, for example, familial or 
genetic f/gCJD [13], Gerstmann-Sträussler-Scheinker syndrome (GSS) [14], fatal 
familial insomnia (FFI) [15], sporadic fatal insomnia (sFI) [16], and variably 
protease-sensitive prionopathy (VPSPr) [17].
Kuru is an interesting form spread among the natives of the Fore linguistic group 
inhabiting the mountainous regions of Papua New Guinea. The disease was studied 
by Gajdusek and coworkers in the 1960s. Based on its similarity to scrapie and 
epidemiological, clinical, and pathohistological features [18], Gajdusek managed to 
reproduce the disease in chimpanzees [19]. The research proved that the disease is 
noncontagious but transmitted by a tribal funeral ritual in which the deceased one’s 
relatives pay their respect by eating his/her undercooked brain [2].
In one way or another, all prion diseases in animals and humans are of social 
and economic importance. It is alarming that human activity—guided by eco-
nomic, ritual, or other considerations—could trigger the evolution of a pathogen 
so that it progressively crosses the barrier between two species within just a few 
decades or turns into a strain characteristic of a specific species or ethnic group. 
This comes to demonstrate, in a negative perspective, how deep and strong an 
effect can unconscious human interference have on biological processes. The 
mechanisms underlying these processes, however, still remain largely unknown. 
That is why, to correctly unravel the pathogenic processes, it is also important 
to gain a deeper understanding of the normal role of the prion protein and the 
processes that accompany it. Hence, this book discusses the normal function 
of the prion protein (PrPC) and its modulatory role in synaptic mechanisms. It 
describes the pathophysiological processes that accompany TSE, such as neu-
rotoxicity, loss of anti-inflammatory protective function, and the mechanisms 
of neuronal death including prion-induced autophagy and apoptosis. In TSE, 
specifically there is accumulation of an isoform of the normal protein (PrPSc) in 
the cytoplasm of neurons. Thus, it is important to understand the mechanism 
underlying this process, which is also reviewed in this book. Another aspect 
outlined here is that some prion diseases show strain variations, which determine 
their development, demonstrating their key role in the development and pro-
gression of TSE.
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